AbbVie Inc.
BG ˙ BUL ˙ US00287Y1091
SecurityBG:4AB / AbbVie Inc.
InstitutionAuxier Asset Management
Latest Disclosed Ownership31,054 shares
Latest Disclosed Value $ 6,753,934
Auxier Asset Management reports 0.46% decrease in ownership of 4AB / AbbVie Inc.

On May 14, 2026 - Auxier Asset Management filed a 13F-HR form disclosing ownership of 31,054 shares of AbbVie Inc. (BG:4AB) valued at $6,753,934 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 17, 2026 disclosing 31,197 shares of AbbVie Inc.. This represents a change in shares of -0.46% during the quarter.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-14 2026-03-31 13F AbbVie COM 00287Y109 31,054 -143 -0.46 6,754 -5.26 0.9699
2026-02-17 2025-12-31 13F AbbVie COM 00287Y109 31,197 -293 -0.93 7,128 -2.24 1.0023
2025-11-19 2025-09-30 13F AbbVie COM 00287Y109 31,490 -1,326 -4.04 7,291 19.70 1.0219
2025-08-15 2025-06-30 13F AbbVie COM 00287Y109 32,816 -190 -0.58 6,091 -11.92 0.8947
2025-05-14 2025-03-31 13F AbbVie COM 00287Y109 33,006 800 2.48 6,915 20.83 1.0307
2025-02-19 2024-12-31 13F AbbVie COM 00287Y109 32,206 -1,233 -3.69 5,723 -13.33 0.8871
2024-11-14 2024-09-30 13F AbbVie COM 00287Y109 33,439 -250 -0.74 6,604 14.28 0.9761
2024-08-13 2024-06-30 13F AbbVie COM 00287Y109 33,689 0 0.00 5,778 -5.80 0.9149
2024-05-08 2024-03-31 13F AbbVie COM 00287Y109 33,689 -1,713 -4.84 6,135 11.81 0.9331
2024-02-22 2023-12-31 13F AbbVie COM 00287Y109 35,402 -833 -2.30 5,486 1.57 0.8876
2023-11-21 2023-09-30 13F AbbVie COM 00287Y109 36,235 -1,040 -2.79 5,401 7.55 0.9215
2023-08-17 2023-06-30 13F AbbVie COM 00287Y109 37,275 2,384 6.83 5,022 -9.68 0.8332
2023-05-15 2023-03-31 13F AbbVie COM 00287Y109 34,891 -407 -1.15 5,561 -2.52 0.9597
2023-02-17 2022-12-31 13F AbbVie COM 00287Y109 35,298 -90 -0.25 5,705 20.11 0.9845
2022-11-15 2022-09-30 13F AbbVie COM 00287Y109 35,388 -250 -0.70 4,749 -12.99 0.9150
2022-08-11 2022-06-30 13F AbbVie COM 00287Y109 35,638 -55 -0.15 5,458 -5.67 0.9748
2022-05-17 2022-03-31 13F AbbVie COM 00287Y109 35,693 -34 -0.10 5,786 19.62 0.9175
2022-03-01 2021-12-31 13F AbbVie COM 00287Y109 35,727 -126 -0.35 4,837 25.08 0.7510
2021-11-18 2021-09-30 13F AbbVie COM 00287Y109 35,853 -179 -0.50 3,867 -4.73 0.6542
2021-08-18 2021-06-30 13F AbbVie COM 00287Y109 36,032 -300 -0.83 4,059 3.23 0.6728
2021-05-17 2021-03-31 13F AbbVie COM 00287Y109 36,332 -850 -2.29 3,932 -1.31 0.6762
2021-03-05 2020-12-31 13F AbbVie COM 00287Y109 37,182 620 1.70 3,984 24.42 0.7394
2021-03-05 2020-09-30 13F AbbVie COM 00287Y109 36,562 1,020 2.87 3,202 -8.25 0.6696
2020-08-20 2020-06-30 13F AbbVie COM 00287Y109 35,542 7,152 25.19 3,490 61.35 0.7699
2020-05-15 2020-03-31 13F AbbVie COM 00287Y109 28,390 -120 -0.42 2,163 -14.30 0.5400
2020-02-21 2019-12-31 13F AbbVie COM 00287Y109 28,510 -150 -0.52 2,524 16.31 0.4699
2019-11-15 2019-09-30 13F AbbVie COM 00287Y109 28,660 10 0.03 2,170 4.18 0.4365
2019-08-15 2019-06-30 13F AbbVie COM 00287Y109 28,650 1,150 4.18 2,083 -6.00 0.4154
2019-05-14 2019-03-31 13F AbbVie COM 00287Y109 27,500 825 3.09 2,216 -9.88 0.4552
2019-02-13 2018-12-31 13F AbbVie COM 00287Y109 26,675 -100 -0.37 2,459 -2.88 0.5477
2018-11-19 2018-09-30 13F AbbVie COM 00287Y109 26,775 4,200 18.60 2,532 21.03 0.4775
2018-08-15 2018-06-30 13F AbbVie COM 00287Y109 22,575 -50 -0.22 2,092 -2.29 0.4187
2018-05-14 2018-03-31 13F AbbVie COM 00287Y109 22,625 -100 -0.44 2,141 -2.59 0.4287
2018-02-14 2017-12-31 13F AbbVie COM 00287Y109 22,725 -50 -0.22 2,198 8.60 0.4218
2017-11-09 2017-09-30 13F AbbVie COM 00287Y109 22,775 -50 -0.22 2,024 22.30 0.4110
2017-08-16 2017-06-30 13F AbbVie COM 00287Y109 22,825 0 0.00 1,655 11.30 0.3381
2017-05-12 2017-03-31 13F AbbVie COM 00287Y109 22,825 2,000 9.60 1,487 14.03 0.3115
2017-02-28 2016-12-31 13F AbbVie COM 00287Y109 20,825 203 0.98 1,304 0.23 0.2835
2016-11-21 2016-09-30 13F AbbVie COM 00287Y109 20,622 -50 -0.24 1,301 1.64 0.2911
2016-08-04 2016-06-30 13F AbbVie COM 00287Y109 20,672 100 0.49 1,280 8.94 0.2930
2016-05-13 2016-03-31 13F AbbVie COM 00287Y109 20,572 300 1.48 1,175 -2.16 0.2783
2016-02-08 2015-12-31 13F AbbVie COM 00287Y109 20,272 0 0.00 1,201 8.88 0.2722
2015-11-12 2015-09-30 13F AbbVie COM 00287Y109 20,272 1,101 5.74 1,103 -14.36 0.2576
2015-08-20 2015-06-30 13F AbbVie COM 00287Y109 19,171 0 0.00 1,288 14.80 0.2682
2015-11-10 2015-03-31 13F/A-1 AbbVie COM 00287Y109 19,171 -7,900 -29.18 1,122 -36.68 0.2266
2015-05-20 2015-03-31 13F AbbVie COM 00287Y109 19,471 1,140
2015-02-17 2014-12-31 13F AbbVie COM 00287Y109 27,071 -300 -1.10 1,772 12.08 0.3536
2014-11-17 2014-09-30 13F AbbVie COM 00287Y109 27,371 -46,050 -62.72 1,581 -61.85 0.3292
2014-08-12 2014-06-30 13F AbbVie COM 00287Y109 73,421 -5,019 -6.40 4,144 2.78 0.8475
2014-05-14 2014-03-31 13F AbbVie COM 00287Y109 78,440 0 0.00 4,032 -2.66 0.8590
2014-02-12 2013-12-31 13F AbbVie COM 00287Y109 78,440 -2,000 -2.49 4,142 15.12 0.8710
2013-11-12 2013-09-30 13F AbbVie COM 00287Y109 80,440 0 0.00 3,598 8.21 0.8328
2013-08-15 2013-06-30 13F AbbVie COM 00287Y109 80,440 80,440 3,325 0.8037
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.